Emergency Management of Moderate Asthma with inhaled ipratropium bromide

Completed

• Conditions: Acute asthma; Respiratory - Asthma

• Registration Number: ACTRN12607000383460
• Lead Sponsor: Dr Emma Wyatt

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-07-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 346

Inclusion Criteria

Children with an acute exacerbation of asthma of moderate severity (ie one or more of SaO2 90-94%, speaking in phrases, moderate to loud wheeze)

Exclusion Criteria

Children less than 2 years or after 16th birthdaychronic respiratory problemwheeze better accounted for by another diagnosisuse of ipratropium bromide in last 6 hoursmarkers of severity (SaO2 less than 90%, cyanosis, unable to speak, silent chest, abnormal conscious state).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rates of admission to hospital from the emergency department[Assessed within hours]

Secondary Outcome Measures

Name	Time	Method
Duration of stay in emergency department/ ward[Measured on discharge];Admission to emergency department observation ward vs general medical ward[Assessed on discharge from hospital]